Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer

Although numerous genetic mutations and amplifications have been identified in pancreatic cancer, much of the molecular pathogenesis of the disease remains undefined. While proteomic and transcriptomic analyses have been utilized to probe and characterize pancreatic tumors, lipidomic analyses have n...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yixing, DiVittore, Nicole A., Young, Megan M, Jia, Zhiliang, Xie, Keping, Ritty, Timothy M., Kester, Mark, Fox, Todd E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030952/
https://www.ncbi.nlm.nih.gov/pubmed/24970174
http://dx.doi.org/10.3390/biom3030435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030952/
https://www.ncbi.nlm.nih.gov/pubmed/24970174
http://dx.doi.org/10.3390/biom3030435

Ejemplares similares